Acute Lymphoblastic Leukemia - An Overview

Dalia Tewary, Jayita Dey Mondal, Samadrita Mukherjee Sardar

Abstract: Acute lymphoblastic leukemia (ALL) is a malignant disorder resulting from the clonal proliferation of lymphoid precursors with arrested maturation. Specific chromosomal translocations in ALL include mainly, the classical t (8; 14) in B-cell ALL, t (4; 11) in infant leukemia and t (9; 22) translocation (that forms the Philadelphia chromosome). Genome-wide profiling using microarrays, candidate gene, and second generation sequencing have provided a number of key insights into the genetic basis of ALL. Treatment for acute lymphoblastic leukemia typically consists of a remission-induction phase, an intensification (or consolidation) phase, and continuation therapy to eliminate residual disease. Allogeneic haemopoietic stem-cell transplantation is the most intensive form of treatment for acute lymphoblastic leukemia as it clearly benefits several subgroups of patients with high-risk acute lymphoblastic leukemia. Although relatively homogeneous at the morphologic and immunophenotypic level, ALL encompasses a family of extremely heterogeneous disorders when examined at the genetic level. More insights are needed to further improve the treatment outcome of patients with ALL.

Keywords: Acute lymphoblastic leukemia ALL, Philadelphia chromosome, translocation, B-cell ALL, T-cell ALL

How to Cite?: Dalia Tewary, Jayita Dey Mondal, Samadrita Mukherjee Sardar, "Acute Lymphoblastic Leukemia - An Overview", Volume 3 Issue 1, January 2014, International Journal of Science and Research (IJSR), Pages: 110-114, https://www.ijsr.net/getabstract.php?paperid=02013752, DOI: https://dx.doi.org/10.21275/02013752